Navigation Links
Hot new manufacturing tool: A temperature-controlled microbe

Many manufacturing processes rely on microorganisms to perform tricky chemical transformations or make substances from simple starting materials. The authors of a study appearing in mBio, the online open-access journal of the American Society for Microbiology, on April 17 have found a way to control a heat-loving microbe with a temperature switch: it makes a product at low temperatures but not at high temperatures. The innovation could make it easier to use microorganisms as miniature factories for the production of needed materials like biofuels.

This is the first time a targeted modification of a hyperthermophile (heat-loving microorganism) has been accomplished, say the authors, providing a new perspective on engineering microorganisms for bioproduct and biofuel formation.

Originally isolated from hot marine sediments, the hyperthermophile Pyrococcus furiosus grows best at temperatures around 100C (212F). P. furiosus is an archaeon, single-celled organisms that bear a resemblance to bacteria, but they excel at carrying out many processes that bacteria cannot accomplish. Like other hyperthermophiles, P. furiosus' enzymes are stable at the high temperatures that facilitate many industrial processes, making it a well-used tool in biotechnology and manufacturing. But not all products can be made at high heat. Some enzymes will only work at lower temperatures.

In the study in mBio, the authors inserted a gene from another organism into P. furiosus and coaxed it to use that gene to make a new product by simply lowering the temperature. The donor organism, Caldicellulosiruptor bescii, prefers to grow at a relatively cool 78C, so the protein product of its gene, lactate dehydrogenase, is most stable at that comparatively low temperature.

The authors of the study inserted the lactate dehyrogenase gene into a strategic spot, right next to a cold shock promoter that "turns on" the genes around it when P. furiosus is out in the cold at 72C. This essentially gives scientists a switch for controlling lactate production: put the organism at 72C to turn on lactate production, restore it to 100C to turn it off, thus preventing the need for chemical inducers. What's more, since P. furiosus is mostly shut down at these lower temperatures, making the new product doesn't interfere with its metabolism, or vice-versa.

The lead author on the study, Michael Adams of the Department of Biochemistry & Molecular Biology at the University of Georgia, explains that this is the key benefit of this system: although P. furiosus now makes the enzyme that carries out the process, at these lower temperatures the organism's other metabolic processes don't get in the way.

"The hyperthermophile is essentially the bioreactor that contains the foreign enzymes," says Adams. P. furiosus just supplies cofactors and a cytoplasmic environment for the highly active foreign enzymes, according to Adams. This makes for a cleaner, more controllable reaction.


Contact: Jim Sliwa
American Society for Microbiology

Related biology news :

1. The shape of things to come: NIST probes the promise of nanomanufacturing using DNA origami
2. Manufacturing microscale medical devices for faster tissue engineering
3. New process for manufacturing nanocellulose recognized with the Empa Research Award
4. Reportlinker Adds Enzymes in Drug Manufacturing
5. Advance in microchannel manufacturing opens new industry applications
6. Discovery of source of glycogen manufacturing errors sheds light on fatal disease
7. Fly eye paves the way for manufacturing biomimetic surfaces
8. Semiconductor Manufacturing International Corporation: Announcement of 2009 Annual Results
9. Manufacturing antibodies
10. Louisiana Techs Institute for Micromanufacturing to collaborate with colleagues in the arts
11. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
Post Your Comments:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology: